Oramed Pharmaceuticals Inc. — Director's Dealing 2012

Aug 9, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP.OB)
CIK: 0001176309
Period of Report: 2012-08-08

Reporting Person: Berelowitz Michael (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-08	Stock Option (right to buy)	$0.34	A	40000	Acquired	2022-08-08	Common Stock (40000)	Direct

Footnotes

F1: 20,000 will vest on each of January 1, 2013 and January 1, 2014.